Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Hold Greggs (GRG) by Royston Wild in The Motley Fool
- Avoid Vianet Group (VNET) by Steve Moore in ShareProphets
- Avoid Future (FUTR) by Steve Moore in ShareProphets
- Avoid Dillistone Group (DSG) by Steve Moore in ShareProphets
- Hold GSK (GSK) by LBBW
- Hold GSK (GSK) by DZ Bank
- Buy Playtech (PTEC) by Deutsche Bank
- Sell AstraZeneca (AZN) by Deutsche Bank
- Buy Anglo American (AAL) by Berenberg
- Buy Shell (SHEL) by Goldman Sachs
- Buy Marks & Spencer Group (MKS) by Goldman Sachs
- Neutral Bunzl (BNZL) by Goldman Sachs
- Buy Linde (0M2B) by UBS
- Buy British Land Company (BLND) by Berenberg
- Buy International Workplace Group (IWG) by Berenberg
- Neutral Glencore (GLEN) by JP Morgan
- Overweight Rio Tinto (RIO) by JP Morgan
- Hold Schroders (SDR) by Jefferies
- Buy Lloyds Banking Group (LLOY) by Ben Martin in The Times - Tempus
- Neutral easyJet (EZJ) by ODDO BHF
AstraZeneca (AZN) Share Price
Health Care Sector
NOTE: This is based on 1,253 open tips for AstraZeneca (AZN)
| Latest Bid : 14,048.00p | Latest Ask : 14,052.00p |
| High Today : 14,060.00p | Low Today : 13,844.00p |
| This Years High : 14,346.00p | This Years Low : 9,667.00p |
| Volume : 831,494 | MKT Cap : £218612M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
AstraZeneca (AZN) Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.AstraZeneca (AZN) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Deutsche Bank | Premium Only | 2026-02-06 07:26:00 06/02/2026 | -1.58% |
| Buy | Goldman Sachs | Premium Only | 2026-01-28 05:51:00 28/01/2026 | 2.07% |
| Buy | Berenberg | Premium Only | 2026-01-28 05:24:00 28/01/2026 | 2.07% |
| Buy | Citi | Premium Only | 2026-01-27 05:33:00 27/01/2026 | 2.20% |
| Buy | Shore Capital | Premium Only | 2026-01-16 14:46:00 16/01/2026 | 0.56% |
AstraZeneca (AZN) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 14,048.00p | Latest Ask : 14,052.00p |
| High Today : 14,060.00p | Low Today : 13,844.00p |
| This Years High : 14,346.00p | This Years Low : 9,667.00p |
| Volume : 831,494 | MKT Cap : £218612M |
AstraZeneca Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest AstraZeneca Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Deutsche Bank | Premium Only | 2026-02-06 07:26:00 06/02/2026 | -1.58% |
| Buy | Goldman Sachs | Premium Only | 2026-01-28 05:51:00 28/01/2026 | 2.07% |
| Buy | Berenberg | Premium Only | 2026-01-28 05:24:00 28/01/2026 | 2.07% |
| Buy | Citi | Premium Only | 2026-01-27 05:33:00 27/01/2026 | 2.20% |
| Buy | Shore Capital | Premium Only | 2026-01-16 14:46:00 16/01/2026 | 0.56% |